
簡介:鹽酸蒽丹西酮二水合物,Ondansetron鹽酸鹽是5-HT3受體拮抗劑,可作為化療后止吐劑。
鹽酸蒽丹西酮二水合物物理化學性質(zhì):
| 
			 密度  | 
			
			 1.27g/cm3  | 
		
| 
			 沸點  | 
			
			 546oC at 760mmHg  | 
		
| 
			 熔點  | 
			
			 178.5-179.5oC  | 
		
| 
			 分子式  | 
			
			 C18H20ClN3O  | 
		
| 
			 分子量  | 
			
			 329.824  | 
		
| 
			 閃點  | 
			
			 284oC  | 
		
| 
			 精確質(zhì)量  | 
			
			 329.129486  | 
		
| 
			 PSA  | 
			
			 39.82  | 
		
| 
			 LogP  | 
			
			 3.9305  | 
		
| 
			 外觀性狀  | 
			
			 白色粉末  | 
		
| 
			 儲存條件  | 
			
			 ?20°C  | 
		
| 
			 水溶解性  | 
			
			 H2O: >5 mg/mL  | 
		
鹽酸蒽丹西酮二水合物詳細介紹:
| 
			 中文名稱:  | 
			
			 鹽酸蒽丹西酮二水合物  | 
		
| 
			 中文別名:  | 
			
			 鹽酸蒽丹西酮二水合物;N-叔丁氧羰基-L-谷氨酸 1-甲酯;帕羅西汀雜質(zhì)A;鹽酸昂丹可瓊;鹽酸昂丹司瓊;鹽酸昂丹司酮  | 
		
| 
			 英文名稱:  | 
			
			 4H-Carbazol-4-one,1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-,hydrochloride (1:1)  | 
		
| 
			 英文別名:  | 
			
			 4H-Carbazol-4-one,1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-,hydrochloride (1:1);Ondansetron Hydrochloride;4H-Carbazol-4-one,1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-,hydrochlo...;Ondansetron (hydrochloride);ONDANSETRON HCL;Ondansetron Hydrochl;Ondansetron hydrochloride dihydrate;1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride;GR 38032;LSUREMONOETHANOLAMID;N-(Hydroxyethyl)oleamide;NSC 665799;ODANSETRON HYDROCHLORIDE DIHYDRATE;OEA;OEA,oleoylethanolamide;oleic acid-N-monoetha;Oleyl monoethanolamide;Ondansetron HCl (Zofran);Ondansetron hydrochloride (Zofran);SN 307  | 
		
| 
			 CAS號:  | 
			
			 99614-01-4  | 
		
| 
			 分子式:  | 
			
			 C18H19N3O.CLH  | 
		
| 
			 分子量:  | 
			
			 329.82  | 
		
| 
			 詳細描述:  | 
			
			 博飛美科提供99614-01-4,鹽酸蒽丹西酮二水合物,Ondansetron HCl,Perfemiker,上?,F(xiàn)貨。 Perfemiker,致力于提供高品質(zhì)、高性價比小分子化合物的產(chǎn)品。 Perfemiker小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應商。 5-HT3受體拮抗劑,Ondansetron鹽酸鹽是5-HT3受體拮抗劑,可作為化療后止吐劑。 查詢關鍵詞:“99614-01-4,鹽酸蒽丹西酮二水合物,Ondansetron HCl,Perfemiker,上?,F(xiàn)貨”。  | 
		
鹽酸蒽丹西酮二水合物參考文獻:
[1]. Brown AM, et al. Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A). J Physiol. 1998 Mar 15;507 ( Pt 3):653-65.
[2]. Barann M, et al. Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):255-65.
[3]. Wildeboer KM, et al. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Res. 2009 Dec 1;1300:41-50.
[4]. Khedhaier A, et al. Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice. Chronobiol Int. 2003 Nov;20(6):1103-16.
[5]. Umathe SN, et al. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Behav Pharmacol. 2009 Feb;20(1):78-83.
[6]. Doggrell SA, et al. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opin Drug Saf. 2013 May;12(3):421-31.
                
                
滬公網(wǎng)安備31011402010658號